MAP2K1 mouse monoclonal antibody,clone OTI4E1
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Products
MAP2K1 mouse monoclonal antibody,clone OTI4E1
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI3E6 (formerly 3E6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Mouse, Rat |
Anti-MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F5 (formerly 1F5)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
热销推荐
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2B7 (formerly 2B7)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F9 (formerly 1F9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
热销推荐
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI6C6 (formerly 6C6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
热销推荐
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1B4 (formerly 1B4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI7B1 (formerly 7B1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
活动过滤器
优化搜索结果
Category
Reactivities
Applications
Antibody Hosts
Knockout (KO) Validation
Modifications
Clonalities
Assay Types
Brands
Families
Pathways
- Acute myeloid leukemia (57)
- B cell receptor signaling pathway (57)
- Bladder cancer (57)
- Chemokine signaling pathway (57)
- Chronic myeloid leukemia (57)
- Colorectal cancer (57)
- Dorso-ventral axis formation (57)
- Endometrial cancer (57)
- ErbB signaling pathway (57)
- Fc epsilon RI signaling pathway (57)
- Fc gamma R-mediated phagocytosis (57)
- Focal adhesion (57)
- Gap junction (57)
- Glioma (57)
- GnRH signaling pathway (57)
- Insulin signaling pathway (57)
- Long-term depression (57)
- Long-term potentiation (57)
- MAPK signaling pathway (57)
- Melanogenesis (57)
- Melanoma (57)
- Natural killer cell mediated cytotoxicity (57)
- Neurotrophin signaling pathway (57)
- Non-small cell lung cancer (57)
- Oocyte meiosis (57)
- Pancreatic cancer (57)
- Pathways in cancer (57)
- Prion diseases (57)
- Progesterone-mediated oocyte maturation (57)
- Prostate cancer (57)
- Regulation of actin cytoskeleton (57)
- Renal cell carcinoma (57)
- T cell receptor signaling pathway (57)
- Thyroid cancer (57)
- Toll-like receptor signaling pathway (57)
- VEGF signaling pathway (57)
- Vascular smooth muscle contraction (57)
